10x Genomics Insiders Sold Shares Worth Over $3.1M
10x Genomics director Shehnaaz Suliman disposes of USD 140,916.11 in common shares
Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
16:33 ETBloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution
Revolution Medicines Earns Buy as RASONQUE FDA Approval and Strong Pricing Outlook Drive Price Target Increase to $315
Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug